🌐EnglishEnglishDeutschPolskiРусскийEntityQ12096645· pop 8Hryhoriy HoloskevychRecent publications · Crossref5 total works indexedTuning superconductivity in twisted bilayer graphene · 2019 · cited 2,056xDurvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial · 2019 · cited 1,863xPembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial · 2020 · cited 1,518xPembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial · 2023 · cited 597xDurvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial · 2021 · cited 584xvia Crossref · CC0Available in 6 languagesРусскийbe_x_oldBelarusianFinnishPolskiUkrainianvia Wikidata sitelinks · CC0